网络药品经营监督管理办法（征求意见稿）(15)
<P style="LINE-HEIGHT: 24pt; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ; mso-line-height-rule: exactly; mso-layout-grid-align: none; mso-char-indent-count: 2.0" class=MsoNormal><SPAN style="FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-ascii-font-family: 'Times New Roman'">（六）发现发布虚假信息、夸大宣传；</SPAN><SPAN style="FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US><o:p></o:p></SPAN></FONT>
<P style="LINE-HEIGHT: 24pt; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ; mso-line-height-rule: exactly; mso-layout-grid-align: none; mso-char-indent-count: 2.0" class=MsoNormal><SPAN style="FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-ascii-font-family: 'Times New Roman'">（七）发现网络药品销售者不具备网络药品销售资质的；</SPAN><SPAN style="FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US><o:p></o:p></SPAN></FONT>
<P style="LINE-HEIGHT: 24pt; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ; mso-line-height-rule: exactly; mso-layout-grid-align: none; mso-char-indent-count: 2.0" class=MsoNormal><SPAN style="FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-ascii-font-family: 'Times New Roman'">（八）发现其他违法违规行为的。</SPAN><SPAN style="FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US><o:p></o:p></SPAN></FONT>
<P style="LINE-HEIGHT: 24pt; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ; mso-line-height-rule: exactly; mso-layout-grid-align: none; mso-char-indent-count: 2.0" class=MsoNormal><SPAN style="FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-ascii-font-family: 'Times New Roman'">对上述涉及违法行为的，还应当立即向食品药品监督管理部门报告。</SPAN><SPAN style="FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US><o:p></o:p></SPAN></FONT>
<P style="LINE-HEIGHT: 24pt; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ; mso-line-height-rule: exactly; mso-layout-grid-align: none; mso-char-indent-count: 2.0" class=MsoNormal><SPAN style="FONT-FAMILY: 黑体; FONT-SIZE: 16pt; mso-font-kerning: 0pt">第二十七条</SPAN><SPAN style="FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-ascii-font-family: 'Times New Roman'">网络药品交易服务平台经营者应当建立投诉举报制度，接到投诉举报后，应当记录并及时处理；建立药品不良反应（事件）信息收集制度，接到药品不良反应报告，应当记录并及时转交药品生产经营企业处理；鼓励网络药品交易服务平台经营者建立消费者权益保证金与先行赔付制度。</SPAN><SPAN style="FONT-SIZE: 16pt; mso-font-kerning: 0pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US><o:p></o:p></SPAN></FONT>
总共28页
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] 15
[16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] 上一页 下一页